photo of Gabriel Bedard

Gabriel Bedard, MD

MD: Albert Einstein College of Medicine

When I interviewed at WashU, I was immediately struck by the pervasive enthusiasm and candor for both the residency training opportunities and the research acumen. It is an extreme honor to have this opportunity to train at a world-class institution with the best and brightest. I am beyond excited to move to St. Louis and start this next chapter with WashU Medicine Otolaryngology.

Home Town: New York City

Education

Undergraduate: BS, Chemistry, State University of new York (SUNY) at Birmingham

MD/PhD: Albert Einstein College of Medicine

Honors & Awards

  • National Cancer Institute (NCI) F30 Research Fellowship, “Rational design of anti-cancer therapeutics harnessing the synthetic lethality of methionine metabolism and arginine methyltransferases” 5F30CA275213, Albert Einstein College of Medicine (2022-2026)
  • JBC Herbert Tabor Early Career Investigator Award (2025)
  • Gold Humanism Honor Society (2026)
  • Summa Cum Laude, SUNY Binghamton (2017)
  • Provost Undergraduate Research Award, SUNY Binghamton (2017-2018)
  • American Chemical Society (ACS) Undergraduate Award in Organic Chemistry (2018)

Publications

  1. G. T. Bedard,  N. Gilaj, K. Peregrina, I. Brew, E. Tosti, K. Shaffer, P. C. Tyler, W. Edelmann, L. H. Augenlicht, V. L. Schramm, “Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition”, Journal of Biological Chemistry, 300, 105492, 2024. 
  2. N. Mahmoodi, Y. V. T. Minnow, R. K. Harijan, G. T. Bedard, V. L. Schramm, “Cell-effective Transition-State Analogue of Phenylethanolamine N-Methyltransferase”, Biochemistry, 62, 2257, 2023.